Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84M Buy
10,802
+258
+2% +$50.3K 0.01% 945
2025
Q4
$2.38M Buy
10,544
+2,564
+32% +$558K 0.01% 787
2025
Q3
$1.52M Buy
7,980
+1,066
+15% +$194K 0.01% 884
2025
Q2
$1.09M Buy
6,914
+4,101
+146% +$617K 0.01% 943
2025
Q1
$496K Buy
2,813
+545
+24% +$106K 0.01% 1134
2024
Q4
$457K Sell
2,268
-72
-3% -$15.2K 0.01% 1113
2024
Q3
$552K Buy
2,340
+1,367
+140% +$323K 0.01% 824
2024
Q2
$206K Buy
+973
New +$221K 0.01% 842

Other funds holding IQV

&Partners's IQV Position: Q1 2026 in Review

&Partners increased its IQVIA (IQV) stake by 2.4% in Q1 2026, buying an estimated $50.3K and bringing the position to 10,802 shares worth $1.84M. The position accounts for 0.01% of the portfolio, ranked #945.

&Partners first reported a position in IQV in Q2 2024 and has held it in 8 quarters since. The position peaked at $2.38M in Q4 2025. 1,066 funds tracked by Wall St. Rank hold IQV as of Q1 2026.

  • &Partners held 10,802 shares of IQVIA worth $1.84M as of Q1 2026.
  • &Partners bought 258 IQVIA shares in Q1 2026, an estimated $50.3K.
  • IQVIA made up 0.01% of &Partners's portfolio in Q1 2026, its #945 holding.
  • &Partners first reported a position in IQVIA in Q2 2024 and has held it in 8 quarters since.
  • &Partners's IQVIA position peaked at $2.38M in Q4 2025.
  • 1,066 funds tracked by Wall St. Rank held IQVIA as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.